WCLC 2025 - Posters & ePosters-P3.18.14 Quick Start Durvalumab: A Phase II Pilot Study of Early Durvalumab Initiation Following Chemoradiation in Unresectable Stage II-III NSCLC

P3.18.14 Quick Start Durvalumab: A Phase II Pilot Study of Early Durvalumab Initiation Following Chemoradiation in Unresectable Stage II-III NSCLC

Asset Subtitle

Stephanie Brinton

Meta Tag

Speaker Stephanie Brinton

Topic Clinical Trials in Progress